AXL Regulates Neuregulin1 Expression Leading to Cetuximab Resistance in Head and Neck CancerMari Iida(University of Wisconsin–Madison), Deric L. Wheeler(University of Wisconsin–Madison)Research SquareDecember 6, 202110.21203/rs.3.rs-951815/v1Cited by 1SaveCiteExport RISWatch citationsRelated PapersOvercoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy|Molecular Cancer|2014|64Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3|PLoS ONE|2013|27AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer|BMC Cancer|2022|16